Khera AV - Search Results

1

Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease.

Aragam KG, Dobbyn A, Judy R, Chaffin M, Chaudhary K, Hindy G, Cagan A, Finneran P, Weng LC, Loos RJF, Nadkarni G, Cho JH, Kember RL, Baras A, Reid J, Overton J, Philippakis A, Ellinor PT, Weiss ST, Rader DJ, Lubitz SA, Smoller JW, Karlson EW, Khera AV, Kathiresan S, Do R, Damrauer SM, Natarajan P. Aragam KG, et al. Among authors: khera av. J Am Coll Cardiol. 2020 Jun 9;75(22):2769-2780. doi: 10.1016/j.jacc.2020.04.027. J Am Coll Cardiol. 2020. PMID: 32498804 Free PMC article.

2

Polyphenols and cholesterol efflux: is coffee the next red wine?

Burke MF, Khera AV, Rader DJ. Burke MF, et al. Among authors: khera av. Circ Res. 2010 Mar 5;106(4):627-9. doi: 10.1161/CIRCRESAHA.109.215855. Circ Res. 2010. PMID: 20203311 Free PMC article. No abstract available.

3

Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics.

Khera AV, Rader DJ. Khera AV, et al. Trends Cardiovasc Med. 2009 Aug;19(6):195-201. doi: 10.1016/j.tcm.2009.12.003. Trends Cardiovasc Med. 2009. PMID: 20211435 Free PMC article. Review.

4

Future therapeutic directions in reverse cholesterol transport.

Khera AV, Rader DJ. Khera AV, et al. Curr Atheroscler Rep. 2010 Jan;12(1):73-81. doi: 10.1007/s11883-009-0080-0. Curr Atheroscler Rep. 2010. PMID: 20425274 Free PMC article. Review.

5

On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study).

Khera AV, Wolfe ML, Cannon CP, Qin J, Rader DJ. Khera AV, et al. Am J Cardiol. 2010 Aug 15;106(4):451-6. doi: 10.1016/j.amjcard.2010.03.057. Am J Cardiol. 2010. PMID: 20691300 Clinical Trial.

6

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, Mohler ER, Rothblat GH, Rader DJ. Khera AV, et al. N Engl J Med. 2011 Jan 13;364(2):127-35. doi: 10.1056/NEJMoa1001689. N Engl J Med. 2011. PMID: 21226578 Free PMC article.

7

The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levels.

Mehta NN, Li M, William D, Khera AV, DerOhannessian S, Qu L, Ferguson JF, McLaughlin C, Shaikh LH, Shah R, Patel PN, Bradfield JP, He J, Stylianou IM, Hakonarson H, Rader DJ, Reilly MP. Mehta NN, et al. Among authors: khera av. Eur Heart J. 2011 Apr;32(8):963-71. doi: 10.1093/eurheartj/ehr091. Epub 2011 Mar 17. Eur Heart J. 2011. PMID: 21415067 Free PMC article. Review.

8

The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.

Patel PJ, Khera AV, Jafri K, Wilensky RL, Rader DJ. Patel PJ, et al. Among authors: khera av. J Am Coll Cardiol. 2011 Nov 8;58(20):2068-75. doi: 10.1016/j.jacc.2011.08.030. J Am Coll Cardiol. 2011. PMID: 22051328 Free article.

9

Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy.

Patel PJ, Khera AV, Wilensky RL, Rader DJ. Patel PJ, et al. Among authors: khera av. Eur J Heart Fail. 2013 Nov;15(11):1215-9. doi: 10.1093/eurjhf/hft084. Epub 2013 May 24. Eur J Heart Fail. 2013. PMID: 23709232 Free PMC article.

10

Cholesterol efflux capacity: full steam ahead or a bump in the road?

Khera AV, Rader DJ. Khera AV, et al. Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1449-51. doi: 10.1161/ATVBAHA.113.301519. Arterioscler Thromb Vasc Biol. 2013. PMID: 23766382 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page